Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

Two new COVID-19 variants are spreading through the U.S., and medical providers in Connecticut are expecting an uptick in cases in the coming weeks.

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

A large-scale global study has identified genetic variants that are risk factors for long COVID, a discovery that helps ...

For long COVID patients, this dynamic is particularly hazardous. Desperate for relief, and often frustrated by the slow ...